SS
Sushila Singh
About Sushila Singh
Data last updated:
Sushila Singh has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Dr Jyotir Bhushan Healthcare & Research Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Dr Jyotir Bhushan Healthcare & Research Private Limited at ₹3.15 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dr Jyotir Bhushan Healthcare & Research Private Limited U85110JH2006PTC012494 | Director | 28 Jun 2006 | 2006 | ₹3.15 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushila Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushila Singh
Sushila Singh has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Dr Jyotir Bhushan Healthcare & Research Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Dr Jyotir Bhushan Healthcare & Research Private Limited at ₹3.15 Cr (FY 2024).
Sushila Singh is associated with 1 company as Director, including Dr Jyotir Bhushan Healthcare & Research Private Limited (₹3.15 Cr).
Sushila Singh has expertise in Healthcare.
Sushila Singh has 20 years in corporate governance.
By reported revenue, the largest current company of Sushila Singh is Dr Jyotir Bhushan Healthcare & Research Private Limited, with revenue of ₹3.15 Cr (FY 2024).
Sushila Singh currently holds positions at 1 company: Dr Jyotir Bhushan Healthcare & Research Private Limited (₹3.15 Cr).